Luisa Ciccarelli
Technik-/Wissenschafts-/F&E-Leiter bei MORPHOSYS AG
Ursprung des Netzwerks ersten Grades von Luisa Ciccarelli
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
27
| Public Company | Biotechnology | 27 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Luisa Ciccarelli
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member President | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Doctorate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
Amgen NV
 Amgen NV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen NV is a pharmaceutical company based in Diegem, Belgium. The Belgian company is focused on developing innovative therapies to address serious illnesses and improve the lives of patients. Amgen is committed to advancing scientific research and delivering high-quality medicines to patients worldwide. The CEO of the company is Gabor Sztaniszlav. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HOOKIPA PHARMA INC. | Biotechnology | Director/Board Member | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Sanofi Pasteur MSD SNC
 Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD SNC is engaged in the wholesale of pharmaceutical products. The company was founded on August 16, 1993 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| Merck KGAA Unsponsored ADR Facility | Corporate Officer/Principal | ||
| University of Antwerp | College/University | Graduate Degree | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director of Finance/CFO | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree | |
| University of California, Irvine | College/University | Undergraduate Degree | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Fresenius Medical Care Management AG
 Fresenius Medical Care Management AG Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Medical Care Management AG is a German company that provides innovative products, therapies, and services to create a livable future for their patients. The company is based in Bad Homburg, Germany. The company specializes in chronic and acute kidney dialysis and therapeutic apheresis. The company was founded in 2005. The CEO is Helen Giza. | Medical Distributors | Director of Finance/CFO | |
| Faculté De Médecine Necker Enfants Malades Université | College/University | Doctorate Degree | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
| VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Boys & Girls Clubs of Metro Los Angeles
 Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Boys & Girls Clubs of Metro Los Angeles is a non-profit organization that was founded in December 2015 to provide a sustainable solution to the opportunity crises facing vulnerable children in the neediest neighborhoods of Los Angeles. Boys & Girls Clubs of Metro Los Angeles is based in Los Angeles, CA, and has subsidiaries in the United States. The organization operates four clubs in Bell Gardens, Challengers, Downs, and Willowbrook, and offers nationally recognized, research-based programs and activities in three core areas: academic success, good character and citizenship, and healthy lifestyles. The organization empowers youth to explore a future with endless possibilities by offering creative programming, such as new approaches to science, technology, engineering, and math (STEM) created in collaboration with community partners. The non-profit company was founded in 2015, and the CEO is Patrick Mahoney. | Miscellaneous Commercial Services | Director/Board Member | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Human Resources Officer | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree | |
| Universität zu Köln | College/University | Graduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Human Resources Officer | |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| École Normale Supérieure | College/University | Graduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| QUANTUM GENOMICS | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| Novo Nordisk SA (Belgium) | Corporate Officer/Principal | ||
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Zurich | College/University | Doctorate Degree | |
| University of Deusto | College/University | Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Graduate Degree | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ecolab GmbH | Corporate Officer/Principal | ||
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
| Eberhard Karls Universität Tübingen | College/University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 23 |
| Deutschland | 14 |
| Frankreich | 8 |
| Belgien | 4 |
| Schweiz | 4 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 15 |
| Distribution Services | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 58 |
| Corporate Officer/Principal | 54 |
| Independent Dir/Board Member | 22 |
| Graduate Degree | 13 |
| Chief Tech/Sci/R&D Officer | 12 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| George Golumbeski | 36 |
| Wendy Johnson | 23 |
| Michael Brosnan | 14 |
| Sharon Curran | 14 |
| Malte Peters | 11 |
| Jean-Paul Kress | 10 |
| Andrew Cheng | 10 |
| Ann Merchant | 8 |
| Krisja Vermeylen | 8 |
| Marc Cluzel | 8 |
| Sung Lee | 7 |
| Tim Demuth | 5 |
| Barbara Krebs-Pohl | 5 |
| Maria Castresana | 5 |
| Charlotte Lohmann | 4 |
- Börse
- Insiders
- Luisa Ciccarelli
- Unternehmensverbindungen